Loading…
← CockpitCompetitor Analysis › GRAUWEIL.NS Grauer & Weil India Ltd.Open in the cockpit ↗

Grauer & Weil India Ltd.GRAUWEIL.NSCompetitor analysis, valuation and peers

India · INR·Chemicals›Chemicals: Specialty
Momentum strong 75
Mkt cap
$367M
US dollars, full cap
Free float
29%
of shares outstanding
$/day
$218,853
20-day average traded
Fwd P/E
n/m
no positive forecast
ROIC−WACC
-5.7 pp
WACC 17.1%
Hurdle
+14 pp
Req g minus delivered
Close · INR₹75.42
1D0.0%
1W-1.6%
1M-2.9%
3M+13.5%
6M+16.7%
YTD+30.5%
1Y+29.4%
ATR %4.0%
52w lowhigh15.0% off high

What Grauer & Weil India does

Employees: 987

Grauer & Weil India at a glance

Size Grauer & Weil India (GRAUWEIL.NS) is an India Materials company (Chemicals: Specialty) with a market value of $367M, the 982nd largest of 1,066 India companies the cockpit tracks. Shares closed at ₹75.42 on 18 Nov 2026.

Performance Over six months the shares gained 16.7%, against -24.2% for the median peer and +3.8% for the India market (cap-weighted) — 3rd highest of 21 in its peer set.

Growth Revenue grew 10.1% over the last twelve months (peer median +12.1%); the operating margin is 13.3% (peer median 4.5%).

Valuation It trades at 2.8× enterprise value to sales against a peer median of 1.0× (6th most expensive of 20).

Price implies For today's price to make sense, revenue must grow about 29% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is +14 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.

Capital Return on invested capital runs 5.7 points below its cost of capital (17.1% WACC).

Relative performance

8010012014021 May 202621 Aug 202618 Nov 2026GRAUWEIL.NS 118Peer median 76
Six months, rebased to 100: Grauer & Weil India against the median of its 20 peers (local-currency closes).

Grauer & Weil India financials

Reported figures in INR; fiscal year ends 2026-03-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
Revenue₹12.4B₹11.9B₹11.3B₹10.7B₹9.81B
Revenue growth—+5%+6%+9%—
Gross profit₹4.64B₹2.70B₹2.52B₹2.46B₹1.94B
EBITDA₹1.89B₹2.00B₹1.94B₹1.94B₹1.58B
Net income₹1.60B₹1.64B₹1.57B₹1.46B₹1.13B
Free cash flown/a₹1.28B₹1.31B₹1.43B₹1.07B
Capital expendituren/a₹537M₹440M₹316M₹145M
Total debtn/a₹145M₹118M₹269M₹244M

Quarterly statements and history in the cockpit →

Grauer & Weil India competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-40%-20%0%+20%-20%-10%0%210830063740780027533010596051666008444221688357ASIX300631STYRENIX6882031714001335RYAMKIRIINDUS300891069260GRAUWEIL.NS6-month return →1-month return →
Up and to the right = strong over both horizons. Grauer & Weil India is the large dot.

Fundamentals: revenue growth against valuation

-50%-25%0%+25%+50%0×2×4×6×21083006374078002753301059605166600844688357ASIXSTYRENIX6882031714001335RYAM300891002742069260GRAUWEIL.NSRevenue growth (TTM) →EV / Sales →
Further right = faster growth; higher = more expensive. The dashed lines are the peer medians. Grauer & Weil India is the large dot.

Capital: growth delivered against growth the price implies

-20%0%+20%+40%-25%0%25%50%30063740783010594221688357ASIX300631STYRENIX6882031714001335RYAM069260GRAUWEIL.NSGrowth delivered (Del g) →Growth the price implies (Req g, 7 yrs) →
Above the diagonal = the price needs more growth than the company has been delivering; below = the price already allows for a slowdown. Grauer & Weil India is the large dot.

Grauer & Weil India competitors and peer comparison

How Grauer & Weil India compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Grauer & Weil India against its 20 peers (data as of 18 Nov 2026)
MeasureGRAUWEIL.NSPeer medianRank in peer set
1-month return-2.9%-9.9%4th highest of 21
6-month return+16.7%-24.2%3rd highest of 21
Distance from 52-week high-15.0%-43.7%2nd highest of 21
Revenue growth (TTM)+10.1%+12.1%10th lowest of 21
Operating margin13.3%4.5%2nd highest of 21
EV / Sales2.8×1.0×6th most expensive of 20
Growth the price implies (Req g, 7 yrs)29.0%13.7%3rd most demanding of 15
Growth delivered (Del g)+14.6%+9.2%4th highest of 15
Hurdle (Req g minus delivered)+14.4 pp+0.1 pp4th most demanding of 15
ROIC minus cost of capital-5.7 pp-3.2 pp6th lowest of 21
EV / EBITDA18.1×4.1×most expensive of 8
Net debt / EBITDA-2.3×0.2×2nd least indebted of 9

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthOp. marginEV / SalesReq gDelivered g
Grauer & Weil India GRAUWEIL.NSIndia$367M+17%+10%13%2.8×29.0%+14.6%
Nantex Industry 2108.TWTaiwan$370M-6%+13%13%0.3×n/an/a
Yangfan New Materials (Zhejiang) 300637.SZChina$361M-9%+12%2%2.7×24.3%+13.4%
Sakai Chemical Industry 4078.TJapan$361M-7%+1%8%0.7×-2.2%-0.8%
Shanxi Yongdong Chemistry Industry 002753.SZChina$373M-16%+18%1%0.8×n/an/a
Jinsanjiang (Zhaoqing) Silicon Material 301059.SZChina$359M-34%+27%20%4.4×7.5%+18.0%
Juheshun Advanced Material 605166.SSChina$359M-37%-19%2%0.7×n/an/a
Danhua Chemical Technology 600844.SSChina$358M-23%-6%-9%3.4×n/an/a
Okura Industrial 4221.TJapan$376M+2%+19%10%0.6×-9.6%+1.4%
Luoyang Jianlong Micro-nano New Materials 688357.SSChina$377M-25%+12%13%2.9×7.8%+13.2%
Advansix ASIXUnited States$380M-34%+8%-1%0.5×52.9%+5.6%
Jiangsu Jiuwu Hi-Tech 300631.SZChina$353M-35%+15%10%2.9×14.9%+3.5%
Styrenix Performance Materials STYRENIX.NSIndia$348M-18%+10%9%1.0×17.5%+16.1%
Zhejiang Hisun Biomaterials 688203.SSChina$386M-5%+47%4%2.0×12.5%+26.6%
Ho Tung Chemical 1714.TWTaiwan$388M+40%+48%10%0.4×-20.6%-1.5%
Trust Chem 001335.SZChina$388M-40%+5%7%2.0×24.6%+5.6%
Rayonier Advanced Materials RYAMUnited States$346M-40%+2%1%0.7×31.7%+1.8%
Kiri Industries KIRIINDUS.NSIndia$344M+26%+30%-22%n/an/an/a
Guangdong Huiyun Titanium Industry 300891.SZChina$344M-30%+2%0%2.0×15.9%+12.8%
Chongqing Jiheng Pharmaceutical 002742.SZChina$340M-30%-48%-20%5.6×n/an/a
TKG Huchems 069260.KSSouth Korea$339M-34%+19%5%0.3×-18.4%+13.7%

Questions

Which companies are Grauer & Weil India's closest peers?
The cockpit's peer set: Nantex Industry (2108.TW), Yangfan New Materials (Zhejiang) (300637.SZ), Sakai Chemical Industry (4078.T), Shanxi Yongdong Chemistry Industry (002753.SZ), Jinsanjiang (Zhaoqing) Silicon Material (301059.SZ), Juheshun Advanced Material (605166.SS), Danhua Chemical Technology (600844.SS), Okura Industrial (4221.T).
Is Grauer & Weil India expensive compared with its peers?
On ev / sales it trades at 2.8× against a peer median of 1.0×, 6th most expensive of 20 in its peer set. For today's price to make sense, revenue must grow about 29% a year for seven years (Req g). Recent delivered growth is +15%, so the hurdle is +14 pp: the price needs faster growth than the company has been delivering — of companies that just grew 25–50% a year, 93.8% slowed down over the next four years.
How has Grauer & Weil India stock performed?
Over six months to 18 Nov 2026 the shares returned +16.7% against -24.2% for the median peer; over one year +29.4%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.